Trial Profile
A study evaluating the effect of Bictegravir/emtricitabine/tenofovir alafenamide on the pharmacokinetics of metformin in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Metformin
- Indications HIV-1 infections
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017